This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Moderna Inc. rose 5.3% to $35.53 on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 2.2% to 19,524.01 and Dow Jones Industrial Average falling 1.7% to 43,428.02.
Moderna Inc. closed 79.2% below its 52-week high of $170.47, which the company achieved on May 24th.
The stock outperformed some of its competitors, as Johnson & Johnson rose 1.6% to $162.30, Pfizer Inc. rose 1.5% to $26.30, and Gilead Sciences Inc. fell 0.07% to $109.95.
Trading volume totaled 21.0 million, compared to the 50-day average of 11.3 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
February 21, 2025 16:35 ET (21:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。